Akiyoshi Ogimoto
Overview
Explore the profile of Akiyoshi Ogimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, et al.
Heart
. 2025 Mar;
PMID: 40037766
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan. Methods: This multicentre, prospective...
2.
Nakaya Y, Akamatsu M, Yakushiji K, Ogimoto A, Kitaoka H
Int Heart J
. 2025 Jan;
66(1):66-73.
PMID: 39828339
Cardiac rehabilitation (CR) improves physical function in patients with acute decompensated heart failure (ADHF) and frailty. However, few studies have assessed physical function through multiple measures during hospitalization; moreover, the...
3.
4.
Tasaka T, Ogimoto A, Saito M, Koike S, Kono T, Ohshima K, et al.
J Nucl Cardiol
. 2024 Nov;
44:102075.
PMID: 39522711
No abstract available.
5.
Kitaoka H, Ieda M, Ebato M, Kozuma K, Takayama M, Tanno K, et al.
Circ J
. 2024 Nov;
89(1):130-138.
PMID: 39505542
Background: Mavacamten, a cardiac myosin inhibitor, significantly improved symptoms and cardiac function vs. placebo in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in EXPLORER-HCM. However, the efficacy and safety profiles...
6.
Hamada M, Ogimoto A, Otani T, Kubota N, Hiasa G, Ikeda S
Int Heart J
. 2024 Jul;
65(4):630-637.
PMID: 39085103
The aim of this study was to differentiate between elderly aortic stenosis (AS) patients with and without cardiovascular complications (CCs).In total, 156 consecutive patients with AS aged ≥ 70 years...
7.
Honda R, Nakao Y, Masuda Y, Ohshima K, Koike S, Kono T, et al.
Circ J
. 2024 Jan;
88(3):435.
PMID: 38191173
No abstract available.
8.
Nakaya Y, Ogimoto A, Kitaoka H
Int Heart J
. 2023 Jul;
64(4):647-653.
PMID: 37460315
Tafamidis improves the prognosis of patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM). Additionally, it delays the decline in exercise tolerance, as observed in the six-minute walking test. However, the changes in...
9.
Nakao Y, Ogimoto A, Yamaguchi O
Eur Heart J Case Rep
. 2023 Apr;
7(4):ytad150.
PMID: 37063374
No abstract available.
10.
Tasaka T, Inaba S, Kono T, Ohshima K, Ogimoto A
Circ J
. 2022 Dec;
87(3):466.
PMID: 36504083
No abstract available.